1. Home
  2. FCEL vs SVRA Comparison

FCEL vs SVRA Comparison

Compare FCEL & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FuelCell Energy Inc.

FCEL

FuelCell Energy Inc.

HOLD

Current Price

$11.60

Market Cap

1.0B

Sector

Energy

ML Signal

HOLD

Logo Savara Inc.

SVRA

Savara Inc.

HOLD

Current Price

$4.43

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCEL
SVRA
Founded
1969
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2005
2009

Fundamental Metrics

Financial Performance
Metric
FCEL
SVRA
Price
$11.60
$4.43
Analyst Decision
Buy
Strong Buy
Analyst Count
11
9
Target Price
★ $21.10
$11.06
AVG Volume (30 Days)
★ 6.7M
2.5M
Earning Date
09-02-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 5.24
N/A
EPS
N/A
★ N/A
Revenue
★ $89,437,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$66.49
$4,347.75
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$5.71
$3.86
52 Week High
$37.88
$7.01

Technical Indicators

Market Signals
Indicator
FCEL
SVRA
Relative Strength Index (RSI) 35.18 38.24
Support Level $6.26 N/A
Resistance Level $14.30 $5.53
Average True Range (ATR) 1.28 0.27
MACD -0.45 -0.02
Stochastic Oscillator 13.31 30.98

Price Performance

Historical Comparison
FCEL
SVRA

About FCEL FuelCell Energy Inc.

FuelCell Energy Inc is a clean energy technology company engaged in the development, design, production, and servicing of high temperature fuel cells for clean electric power generation. The Company provides proprietary molten carbonate fuel cell systems that generate electricity electrochemically with ultra low emissions and high efficiency, and operates as a solutions provider managing the design, manufacturing, installation, and maintenance of its systems under long term power purchase, service, and engineering procurement agreements. The Company serves utilities, data centers, and commercial and industrial customers, and operates in the United States, South Korea, Europe, and Canada, with maximum revenue generated from the United States.

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Share on Social Networks: